Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

Release Jan. 10 - Passage Bio: The Philadelphia-based genetic medicines company is planning to lay off about 55% of its staff as it pivots from an in-house to outsourced analytical testing model.

Duke Energy Chair and CEO Lynn Good says the company is working toward retiring coal as part of its climate goals. Speaking on "Bloomberg The Close." Duke removed a mention of climate targets in ...